Search peptides, terms, sources/
Research source · 2022

Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
Adults with obesity/overweight, without diabetes
Sample size
2539
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 August 2026

Limitations

Sponsor-funded (Eli Lilly).

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.